Pharmaceutical Research

, 27:115 | Cite as

Efficiency of Fatty Acids as Chemical Penetration Enhancers: Mechanisms and Structure Enhancement Relationship

Research Paper



The present study evaluated the effects of fatty acids commonly present in cosmetic and topical formulations on permeation enhancement across human epidermal membrane (HEM) lipoidal pathway when the fatty acids saturated the SC lipid domain without cosolvents (Emax).


HEM was treated with neat fatty acids or fatty acid suspensions to determine Emax. A volatile solvent system was used to deposit fatty acids on HEM surface to compare fatty acid enhancer efficiency in topical volatile formulations with Emax. To elucidate permeation enhancement mechanism(s), estradiol (E2β) uptake into fatty acid-treated SC lipid domain was determined.


Emax of fatty acids was shown to increase with their octanol solubilities and decrease with their lipophilicities, similar to our previous findings with other enhancers. Emax of solid fatty acids was shown to depend on their melting points, an important parameter to the effectiveness of the enhancers. The E2β uptake results suggest that enhancer-induced permeation enhancement across HEM is related to enhanced permeant partitioning into the SC lipid domain.


The results suggest Emax as a model for studying the permeation enhancement effect of the fatty acids and their structure enhancement relationship.

Key Words

chemical penetration enhancers corticosterone Emax estradiol fatty acids skin 



This research was supported in part by NIH Grant GM 063559. The authors thank Dr. Jinsong Hao for her help in the laboratory.


  1. 1.
    Al-Qallaf B, Das DB, Mori D, Cui Z. Modelling transdermal delivery of high molecular weight drugs from microneedle systems. Philosophical Transactions of the Royal Society a-Mathematical Physical and Engineering Sciences. 2007;365:2951–67.CrossRefGoogle Scholar
  2. 2.
    Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S. Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci U S A. 2005;102:4688–93.CrossRefPubMedGoogle Scholar
  3. 3.
    Ansel HC, Allen LV, Popovich NG. Pharmaceutical dosage forms and drug delivery systems. Philadelphia: Lippincott-Williams & Wilkins; 1999.Google Scholar
  4. 4.
    El-Gibaly I, Mohamed FA, Shehata M. Effect of some penetration enhancers on release of clotrimazole from different gel formulations and histological changes of rabbit skin. Pharmazeutische Industrie. 1998;60:1088–95.Google Scholar
  5. 5.
    Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci. 1999;88:955–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Chantasart D, Sa-Nguandeekul P, Prakongpan S, Li SK, Higuchi WI. Comparison of the effects of chemical permeation enhancers on the lipoidal pathways of human epidermal membrane and hairless mouse skin and the mechanism of enhancer action. J Pharm Sci. 2007;96:2310–26.CrossRefPubMedGoogle Scholar
  7. 7.
    Ogiso T, Paku T, Iwaki M, Tanino T. Percutaneous penetration of fluorescein isothiocyanate-dextrans and the mechanism for enhancement effect of enhancers on the intercellular penetration. Biol Pharm Bull. 1995;18:1566–71.PubMedGoogle Scholar
  8. 8.
    Goates CY, Knutson K. Enhanced permeation and stratum corneum structural alterations in the presence of dithiothreitol. Biochim Biophys Acta. 1993;1153:289–98.CrossRefPubMedGoogle Scholar
  9. 9.
    Niazy EM. Influence of oleic-acid and other permeation promoters on transdermal delivery of dihydroergotamine through rabbit skin. Int J Pharm. 1991;67:97–100.CrossRefGoogle Scholar
  10. 10.
    Chantasart D, Li SK, He N, Warner KS, Prakongpan S, Higuchi WI. Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci. 2004;93:762–79.CrossRefPubMedGoogle Scholar
  11. 11.
    Ibrahim SA, Li SK. Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement Emax. J Pharm Sci. 2009;98:926–44.CrossRefPubMedGoogle Scholar
  12. 12.
    Karande P, Jain A, Mitragotri S. Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J Control Release. 2006;115:85–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Morgan TM, Parr RA, Reed BL, Finnin BC. Enhanced transdermal delivery of sex hormones in swine with a novel topical aerosol. J Pharm Sci. 1998;87:1219–25.CrossRefPubMedGoogle Scholar
  14. 14.
    Ibrahim SA, Li SK. Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax. J Control Release. 2009;136:117–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Cooper ER. Increased skin permeability for lipophilic molecules. J Pharm Sci. 1984;73:1153–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Barry BW, Bennett SL. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol. 1987;39:535–46.PubMedGoogle Scholar
  17. 17.
    Kandimalla K, Kanikkannan N, Andega S, Singh M. Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo. J Pharm Pharmacol. 1999;51:783–90.CrossRefPubMedGoogle Scholar
  18. 18.
    Aungst BJ. Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res. 1989;6:244–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Aungst BJ, Rogers NJ, Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty-acids, fatty alcohols, surfactants. sulfoxides and amides. Int J Pharm. 1986;33:225–34.CrossRefGoogle Scholar
  20. 20.
    Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res. 1991;8:350–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Nanayakkara GR, Bartlett A, Forbes B, Marriott C, Whitfield PJ, Brown MB. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. Int J Pharm. 2005;301:129–39.CrossRefPubMedGoogle Scholar
  22. 22.
    Yokomizo Y, Sagitani H. The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers. J Control Release. 1996;42:37–46.CrossRefGoogle Scholar
  23. 23.
    Kasting GB, Bowman LA. Electrical analysis of fresh, excised human skin: a comparison with frozen skin. Pharm Res. 1990;7:1141–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Warner KS, Li SK, He N, Suhonen TM, Chantasart D, Bolikal D, Higuchi WI. Structure-activity relationship for chemical skin permeation enhancers: probing the chemical microenvironment of the site of action. J Pharm Sci. 2003;92:1305–22.CrossRefPubMedGoogle Scholar
  25. 25.
    S.A. Ibrahim and S.K. Li. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. Int J Pharm. In Press (2009).Google Scholar
  26. 26.
    S.H. Yalkowsky and R.M. Dannenfelser. Aquasol Database of Aqueous Solubility., Version 5, 1992.Google Scholar
  27. 27.
    Nair VB, Panchagnula R. Effect of iontophoresis and fatty acids on permeation of arginine vasopressin through rat skin. Pharmacol Res. 2003;47:563–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Pharmaceutical Sciences, College of PharmacyUniversity of CincinnatiCincinnatiUSA

Personalised recommendations